Do women have to come off DAFNE when pregnant?
|
|
- Gerard Bell
- 5 years ago
- Views:
Transcription
1 Do women have to come off DAFNE when pregnant? Dr Helen R Murphy hm386@medschl.cam.ac.uk DAFNE Manchester June
2 Topics for discussion Current practice in T1D pregnancy Reflect on current DAFNE guidelines Advantages of DAFNE (pre-pregnancy, antenatal and post pregnancy) Discuss limitations of DAFNE Top tips for advanced management DAFNE bucket list
3 Fetal development at 5 weeks 5 week human fetus
4 Early Cardiac Development Srivastava D, Nature 2000
5 Early neural tube development
6 400,00 singleton pregnancies, 1677 diabetes 9,488 1 malformation, 129 diabetes HbA1c % (mmol/mol) 1000 Pregnancy 6.5 (48) in (53) in (58) in (64) in (80) in /1,000 pregnancies, RR 3.8 OR 1.3 per 1% HbA1c >6.3% (11>45mmol/mol) Bell R Diabetologia 2012
7 Risk of congenital malformation/perinatal mortality <8% With PPC this falls to <1.5% PPC (n=181) No PPC (n=499) p Pre-pregnancy 7.2% 8.1% < st trimester 6.9% 7.4% < nd trimester 6.4% 6.5% rd trimester 6.4% 6.5% 0.05 HbA1c <7.0% (53mmol/mol) HbA1c < 6.1% (43 mmol/mol) 53% 38% < % 10% < Murphy HR Diab Care 2010
8 National Pregnancy in Diabetes Audit 1700 pregnancies 128 NHS Trusts 55% T1D 45%T2D Type 1D Pregnancy 50% PPC LGA/macrosomia 53% Preterm delivery 37% Neonatal care admission 40% Type 2D pregnancy 33% PPC LGA/Macrosomia 25% Preterm delivery 20% NPID Headlines Improvements in T2D pregnancy - access to PPC T1D outcomes unchanged need to optimise day-to-day BG control
9 Does DAFNE do enough re PPC? Diabetes and Pregnancy Project
10 HbA1c goals Diabetes and Pregnancy Project HbA1c 6.5%(48)= 1:33 HbA1c 7% (53) = 1:25 HbA1c> 8% (64) = 1:15 HbA1c >10% (86)- pregnancy NOT recommended.
11 Folic Acid Diabetes and Pregnancy Project Reduces primary NTD 60%; May reduce risk of congenital heart defects; May reduce the risk of orofacial clefts; May increase multiple births??
12 Medications Diabetes and Pregnancy Project Stop statins midline CNS/limb defects (pravastatin preferred) Stop ACE/AII inhibitors Switch to Nifedipine +/- Labetalol (rarely Me Dopa) Continue antidepressants as required
13
14 Has DAFNE kept up with new Technologies? Retrospective/Professional CGMS Real-time/Personal CGM Sensor augmented pump (SAP)/LGS Closed Loop/Artificial Pancreas
15 7 day CGM profile T1D pregnancy
16 Time with BGL (%) CGM profiles in T1 & T2D pregnancy Type 1 DM Type 2 DM p= T1 vs T2 DM p< increase over time Gestation (weeks) Murphy HR Diab Care 07
17 Time with BGL <3.5 (%) Hypoglycaemia in T1 & T2D pregnancy Type 1 DM Type 2 DM p=0.03 T1 vs T2 DM Gestation (weeks) Hewapathiraana N Curr Diab Rep 2012
18 Mean HbA1c (%) CGMS as Educational tool Mean HbA1c 6.4+/-0.7% Standard Care vs. 5.8%+/-0.6 CGMS (p=0.007) Std care CGMS p= Gestational age (weeks)
19 Impact of CGMS on infant birth weight Median birth weight percentile 93 Standard Care vs. 69 CGM, p= Standard care CGM Reduced risk of LGA: Odds ratio 0.36 (95% CI ; p = 0.05) Murphy HR et al, BMJ 2008
20 EFFICIENCY OF REAL-TIME CGM IN PREGNANT WOMEN WITH DIABETES A RANDOMIZED CONTROLLED TRIAL To assess whether intermittent real-time CGM, as part of routine pregnancy care, improves glycaemic control and pregnancy outcome in women with pregestational diabetes AL Secher, L Ringholm, HU Andersen, P Damm, ER Mathiesen, Diabetes Care, Epub Jan
21 SUBGROUP ANALYSES RT-CGM Controls Type 1 diabetes (60 vs. 59) LGA infant Preterm delivery and/or severe neonatal hypoglycaemia Per-protocol (49 vs. 73) LGA infant Preterm delivery and/or severe neonatal hypoglycaemia 50% (30) 32% (18) 49% (25) 24% (11) 36% (21) 27% (16) 34% (22) 22% (16)
22 Matching insulin to food in real-life? Casey et al, BMC Public Health 2011 Lawton et al, Diab Res & Clin Pract 2011
23 Conclusions/Lessons Learned 1. Intermittent RT-CGM not helpful in this cohort (good baseline HbA1c & poor compliance) 2. CGM limited impact on hypoglycaemia exposure 3. Sensor discrepancy, discomfort, alarms annoying. CGM is burdensome; takes time, effort approx 1hr /day! 4. Qualitative data helped but CGM implementation is very variable
24 Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial D Feig (Co-PI), H Murphy (Co-PI), R Corcoy, M Hod, L Jovanovic,
25 International multi-centre, open label, intention-to-treat RCT n=324 2 parallel randomized controlled trials ( 110 prepregnant, 214 pregnant) Stratified by Mode of insulin therapy (Pump or MDI) Baseline HbA1c (>8.0 prepregnant, >7.5% pregnant) Focus on reducing maternal hyperglycaemia using CGM to deliver personalised education & insulin dose adjustment, pre-meal algorithms and adjustment for trends Will RT-CGM improve glycaemic control in women who are pregnant with T1D, or planning pregnancy, as measured by the change in HbA1c at 24/34 weeks clinicaltrials.gov NCT
26 Circadian changes in CGM glucose from UK and Danish cohorts Glucose levels with 95% pointwise confidence intervals Data Graham Law, George Ellison & Eleanor Scott University of Leeds (TIME research group) Diab Care Feb 2015
27 CSII rationale Pickup J NEJM 2012
28 CSII stable basal insulin replacement
29 Mean postprandial glucose excursions from 0 to 300 min for 33 subjects after test meals of LF/LP ( ), LF/HP ( ), HF/LP ( ), and HF/HP ( ) content. Carmel E.M. Smart et al. Dia Care 2013;36: by American Diabetes Association
30 Carbohydrate metabolism in T1D pregnancy 50 dinner & prandial bolus Murphy HR et al, Diabetologia 2012 breakfast & prandial bolus early gestation late gestation 40 Ra ( mol/kg/min) :00 20:00 22:00 00:00 02:00 04:00 06:00 08:00 10:00 12:00 Time (hh:mm) No changes in postprandial Ra in early vs. late pregnancy; p=0.61 Ra t50% 109±24 vs. 97±39min dinner and 58±18 vs. 52±33min breakfast
31 Delayed postprandial glucose disposal 50 dinner & prandial bolus breakfast & prandial bolus Rd ( mol/kg/min) early gestation late gestation :00 20:00 22:00 00:00 02:00 04:00 06:00 08:00 10:00 12:00 Time (hh:mm) Postprandial Rd significantly reduced late pregnancy; P=0.003 Rd t50% 112 ± 22 vs. 142 ± 34 dinner and 103 ± 17 vs. 125 ± 21 breakfast
32 Insulin pharmacokinetics in T1D pregnancy Plasma insulin concentration (pmol/l) dinner & prandial bolus 14:00 16:00 18:00 20:00 22:00 00:00 02:00 04:00 06:00 08:00 10:00 12:00 Time (hh:mm) breakfast & prandial bolus early gestation late gestation Tmax 53±13 vs. 79±33min dinner; 46±10 vs. 78±34min breakfast; p=0.0002
33 Structured Diet and Exercise 14 Structured Exercise Free Living 12 Sensor glucose (mmol/l) :00 16:00 18:00 20:00 22:00 00:00 02:00 04:00 06:00 08:00 10:00 12:00 Time (hh:mm) Overnight MBG 7.5±3.1 vs. 5.2±1.5mmol/l; p=0.05 Kumareswaran K, Diab Care Epub Feb 2013
34 Clinical Practice Dietary attention (20-30g CHO breakfast, 40-50g lunch, dinner) Pre-meal boluses required (15 10 minutes early, 45 15mins late pregnancy) Post-meal exercise mins walking
35 DAFNE bucket list PPC most important intervention in T1 pregnancy targeted information all women years Pregnancy modules DAFNE grads & Novices (on-line, Face-2-Face, group) Huge variability CHO metabolism/insulin kinetics Impact of maternal diet & physical activity Integration of CGM & CSII into DAFNE curriculum before & during pregnancy
36 Thanks to all participating women
37 Acknowledgments AP Team at Cambridge Roman Hovorka Lalantha Leelarathna David B Dunger Janet M Allen Daniela Elleri Kavita Kumareswaran Zoe Stewart Nilu Hewapathiraana Julie Harris Josephine Hayes Marianna Nodale Angie Watts Malgorzata E Wilinska Kings College London Stephanie Amiel Funders JDRF AP Consortium (Aaron Kowalski) Diabetes UK/NIHR Abbott Diabetes Care/Animas (Johnsons & Johnsons)/Medtronic Key collaborators Health Psychology Prof TC Skinner Gerry Rayman/Jonathan Roland/Rosemary Temple
Maternal and Fetal Complications in Diabetes Pregnancy
Maternal and Fetal Complications in Diabetes Pregnancy Helen R Murphy Professor of Medicine (Diabetes & Antenatal Care), UEA Professor of Women s Health, Kings College London hm386@medschl.cam.ac.uk 1
More informationWhat is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?
What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk
More informationContinuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial Dr Sandra Neoh on behalf of: Dr Denice Feig and Professor Helen Murphy Funders: JDRF (Juvenile Diabetes Research Foundation),
More informationCounting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice
Welcome to Allied Health Telehealth Virtual Education Counting the Carbs, Fats and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Dr Carmel Smart, PhD Senior Specialist Paediatric
More informationAchieving optimal glycemic control throughout pregnancy
DIABETES TECHNOLOGY & THERAPEUTICS Volume 20, Number 7, 2018 Mary Ann Liebert, Inc. DOI: 10.1089/dia.2018.0060 BRIEF REPORT Adaptability of Closed Loop During Labor, Delivery, and Postpartum: A Secondary
More informationPregnancy workshop. 25 th April 2014 Caroline Byrne
Pregnancy workshop 25 th April 2014 Caroline Byrne Topics for Discussion Need for good control, pre pregnancy counselling How good control changes outcomes Using CSII in routine care Practical aspects
More information1. What s the point of a network the case for research? 2. How to use CSII effectively
1. What s the point of a network the case for research? 2. How to use CSII effectively John Pickup King s College London Faculty of Medicine Guy s Hospital, London What should an insulin pump network do?
More informationEAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK. Optimising Glycaemic Control for Children and Young People with Diabetes
EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK Optimising Glycaemic Control for Children and Young People with Diabetes Local diabetes teams need to take on the responsibility of ensuring
More informationNote: for non-commercial purposes only. A collaboration between Abbott Nutrition and King s College London
Note: for non-commercial purposes only Women s Health Academic Centre A pilot study to evaluate the effects of a dietary supplement with slow digesting-low GI (SD-LGI) carbohydrates in obese pregnant women
More informationEffective Health Care Program
Comparative Effectiveness Review Number 57 Effective Health Care Program Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness Executive Summary Background Diabetes mellitus is
More informationPregestational Diabetes in Pregnancy. An Update
Pregestational Diabetes in Pregnancy An Update Disclosures D. Ware Branch, MD Nothing to disclose Questions to Be Addressed What are risks factors for adverse pregnancy outcome in pregestational diabetes?
More informationVishwanath Pattan Endocrinology Wyoming Medical Center
Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected
More informationThe artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes
The artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes Roman Hovorka PhD FMedSci University of Cambridge, UK Duality of interest declaration Advisory Panel: Research
More informationCase Study: Competitive exercise
Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia
More informationHow I use the latest technology to investigate and treat a person with Type 1 Diabetes. Dr Pratik Choudhary
How I use the latest technology to investigate and treat a person with Type 1 Diabetes Dr Pratik Choudhary Disclosures Advisory board and speaker fees from Medtronic, Roche, Abbott and Johnson and Johnson,
More informationDiabetes in obstetric patients
Diabetes in obstetric patients Swedish Society of Obstetric Anaesthesia & Intensive Care Anita Banerjee Obstetric Physician Diabetes & Endocrinology Consultant Outline Scope of the problem Diabetes and
More informationGestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)
Gestational Diabetes in Resouce Limited Area Prof Satyan Rajbhandari (RAJ) Case History RP, 26F Nepali girl settled in the UK Primi Gravida BMI: 23 FH of type 2 DM 75 gm Glucose OGTT in week 25 0 Min
More informationDo fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD
Do fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD Objectives Understand the effect of fat and protein on glycemic excursion in the post-prandial
More informationUse of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes
DOI 10.1186/s13098-016-0161-5 Diabetology & Metabolic Syndrome RESEARCH Open Access Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes
More informationWhat is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming
The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,
More informationNational Pregnancy in Diabetes Audit Report, England, Wales and the Isle of Man 12th October 2017
National Pregnancy in Diabetes Audit Report, 2016 England, Wales and the Isle of Man 12th October 2017 Prepared in collaboration with: The National Pregnancy in Diabetes (NPID) audit is part of the National
More informationThe next five years in diabetes technology: closed-loop systems
The next five years in diabetes technology: closed-loop systems J. H. (Hans) DeVries Academic Medical Center at the University of Amsterd, the Netherlands Keystone, CO, 19 July 2013 Disclosure AP@home,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Stewart ZA, Wilinska ME, Hartnell S, et al. Closed-loop insulin
More informationCOMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)
COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa
More informationFaculty Disclosure. No, nothing to disclose Yes, please specify: Medtronic Johnson & Johnson. Ownership/ Equity Position.
Diabeloop Closed-Loop does better than Sensor-augmented Pump on blood glucose control during 3 days with gastronomic dinners: a randomized crossover trial in Patients with Type 1 Diabetes. Hélène Hanaire
More informationPrevention and Management of Diabetes in Pregnancy
Prevention and Management of Diabetes in Pregnancy Sridhar Chitturi Consultant Endocrinologist Royal Darwin Hospital Outline of the talk Diabetes in Pregnancy Spectrum Diagnostic criteria Why bother about
More informationAnneloes Kerssen, a Harold W. de Valk, b Gerard H.A. Visser a. D RCOG 2004 BJOG: an International Journal of Obstetrics and Gynaecology
BJOG: an International Journal of Obstetrics and Gynaecology September 2004, Vol. 111, pp. 919 924 DOI: 10.1111/j.1471-0528.2004.00203.x Day-to-day glucose variability during pregnancy in women with Type
More informationPregnancy and Diabetes
Pregnancy and Diabetes Aim(s) and objective(s) This guideline aims to highlight the importance of maintaining good glycaemic control in women of childbearing age contemplating pregnancy, during pregnancy
More informationDAFNE (Dose Adjustment For Normal Eating)
DAFNE (Dose Adjustment For Normal Eating) Promoting the Expert Patient Professor David McIntyre Mater Health Services and University of Queensland Brisbane AUSTRALIA DAFNE and OzDAFNE Outline Context of
More informationControl of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim
Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine Conflict of interest
More informationMANAGEMENT OF DIABETES IN PREGNANCY
MANAGEMENT OF DIABETES IN PREGNANCY Ministry of Health Malaysia Malaysian Endocrine & Metabolic Society Perinatal Society of Malaysia Family Medicine Specialists Association of Malaysia Academy of Medicine
More informationInsulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)
Insulin Pump Therapy in children Prof. Abdulmoein Al-Agha, FRCPCH(UK) aagha@kau.edu.sa Highlights Evolution of insulin pump Pumps mimics Pancreas Goals of diabetes care What lowers HbA1c Criteria for selection
More information15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016
15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 Sponsored by: Abbott Diabetes Care and Lilly Diabetes Type 1 and exercise Royal Berkshire Hospital Centre for Diabetes and Endocrinology
More informationPersonal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup
1 Personal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup King s College London School of Medicine, Guy s Hospital, London SE1 9RT Experience of the technology I am the lead
More informationContinuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial Denice S Feig, Lois E Donovan, Rosa Corcoy, Kellie E Murphy, Stephanie
More informationDiabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections. Aaron Michels MD
Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections Aaron Michels MD Outline SMBG & CGM by age group JDRF CGM Trial Sensor Augmented Insulin Pump Therapy for A1c Reduction
More informationWhite Rose Research Online URL for this paper: Version: Accepted Version
This is a repository copy of Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial. White Rose Research Online
More information15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016
15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 Sponsored by: Abbott Diabetes Care and Lilly Diabetes The REPOSE Trial (Relative Effectiveness of Pumps over Structured Education) Background
More informationRESEARCH. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial
Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial Helen R Murphy, senior research fellow, 1 Gerry Rayman, consultant physician, 1 Karen Lewis, diabetes
More informationDiabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)
Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing
More informationdelivery during Type 1 diabetes pregnancy
Women s experiences of day-and-night closed-loop insulin delivery during Type 1 diabetes pregnancy Conor Farrington PhD 1, Zoe Stewart MD 2, 3, Roman Hovorka PhD 2 and Helen Murphy MD 2,4 1 THIS Institute,
More informationHypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier??
Hypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier?? Moshe Phillip Institute of Endocrinology and Diabetes National Center of Childhood Diabetes Schneider
More informationContinuous or Intermittent Glucose Monitoring in Interstitial Fluid
Continuous or Intermittent Glucose Monitoring in Interstitial Fluid Policy Number: 1.01.20 Last Review: 9/2018 Origination: 11/2001 Next Review: 9/2019 Policy Blue Cross and Blue Shield of Kansas City
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid Page 1 of 39 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Continuous or Intermittent Monitoring
More informationDIABETES WITH PREGNANCY
DIABETES WITH PREGNANCY Prof. Aasem Saif MD,MRCP(UK),FRCP (Edinburgh) Maternal and Fetal Risks Diabetes in pregnancy is associated with risks to the woman and to the developing fetus. Maternal and Fetal
More informationDiabetes and pregnancy
Diabetes and pregnancy Elisabeth R. Mathiesen Professor, Chief Physician, Dr.sci Specialist in Endocrinology Centre for Pregnant Women with Diabetes Rigshospitalet, University of Copenhagen Denmark Gestational
More informationDiabetes in Pregnancy Registrar Induction. Dr Anna Dover August 31 st 2015
Diabetes in Pregnancy Registrar Induction Dr Anna Dover August 31 st 2015 Outline Joint Antenatal Diabetes Service Pre-existing diabetes Pre-conception, antenatal management Gestational Diabetes Screening,
More informationGESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar. Simon Kane March 2016
GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar Simon Kane March 2016 Objectives History and definitions Definition and Australian data Pathophysiology and prevalence Rationale
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid Page 1 of 26 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Continuous or Intermittent Monitoring
More informationPREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)
PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) Pathways for Future Treatment and Management of Diabetes H. Peter Chase, MD Carousel of Hope Symposium Beverly Hilton, Beverly
More informationManagement of Pregestational and Gestational Diabetes Mellitus
Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is
More informationAngela Girelli e Giorgio Grassi. Stato dell arte del paziente in SAP Ipoglicemia e variabilità glicemica
Angela Girelli e Giorgio Grassi Stato dell arte del paziente in SAP Ipoglicemia e variabilità glicemica Le basi sperimentali Glycemia Ceriello A:Diabetes 2008: 57: 1349 1354 17.50 15.50 Glycemia (mmol/l)
More informationEmerging Automated Insulin Delivery Systems
Emerging Automated Insulin Delivery Systems Richard M. Bergenstal, MD International Diabetes Center Park Nicollet & HealthPartners Minneapolis, MN Presenter Name 1 Dualities: Richard M. Bergenstal, MD
More informationClosed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes
The new england journal of medicine From the Wellcome Trust Medical Research Council Institute of Metabolic Science, University of Cambridge (Z.A.S., M.E.W., R.H., H.R.M.), and Wolfson Diabetes and Endocrine
More informationDiabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE
Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid Page 1 of 42 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Continuous or Intermittent Monitoring
More informationPolicy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age)
Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (
More informationDiabetes Management Continuous Glucose Monitoring
Progress with Closed-loop Systems in Type 1 Diabetes Lalantha Leelarathna 1 and Roman Hovorka 2 1. Clinical Research Associate; 2. Principal Research Associate, Institute of Metabolic Science, University
More informationTHE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.
THE SHEFFIELD AREA PRESCRIBING GROUP Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes Date: March 2018 Overview Freestyle Libre is a flash glucose sensor device that measures *interstitial
More informationInsulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness
Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More informationGestational Diabetes Mellitus Dr. Fawaz Amin Saad
Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.
More informationEarly Intervention in Pregnancy
Early Intervention in Pregnancy Dr Lucy Mackillop Obstetric Physician Honorary Senior Clinical Lecturer Women s Centre Oxford University Hospitals NHS Foundation Trust TVSCN conference 17 th January 2017
More informationWessex Strategic Clinical Networks. Wessex Guidance on supporting women with diabetes to prepare for pregnancy
Wessex Strategic Clinical Networks Wessex Guidance on supporting women with diabetes to prepare for pregnancy February 2016 Wessex Strategic Clinical Network (SCN) Project Group SCN Role Department Contact
More informationDiabetes in Pregnancy Registrar Induction Programme. Dr Anna Dover August 29 th 2016
Diabetes in Pregnancy Registrar Induction Programme Dr Anna Dover August 29 th 2016 Diabetes in pregnancy Why it matters What our service looks like How we diagnose and manage GDM Patients with pre-existing
More informationDownloaded on T23:24:54Z. Title. Different insulin types and regimens for pregnant women with preexisting. Author(s)
Title Author(s) Different insulin types and regimens for pregnant women with preexisting diabetes O'Neill, Sinéad M.; Kenny, Louise C.; Khashan, Ali S.; West, Helen M.; Smyth, Rebecca M. D.; Kearney, Patricia
More informationDAFNE Collaborative Meeting 22 June 2012, Manchester Speakers and Facilitator Biographies
DAFNE Collaborative Meeting 22 June 2012, Manchester Speakers and Facilitator Biographies Anita Beckwith Lead Diabetes Specialist Dietitian, King s College Hospital Anita Beckwith is the Lead Diabetes
More informationUpdate on Continuous Glucose Monitoring (CGM) Technology in Diabetes. Elena Toschi, MD November 12, 2016
Update on Continuous Glucose Monitoring (CGM) Technology in Diabetes Elena Toschi, MD November 12, 2016 Presenter Disclosure Information Elena Toschi, MD No financial disclosure Objectives: Use of CGM
More informationDISCOVER THE POWER OF CONNECTION MINIMED 640G
DISCOVER THE POWER OF CONNECTION MINIMED 640G INSULIN PUMP THERAPY CHANGING LIVES TODAY Have you just been diagnosed with insulin dependent diabetes? Perhaps you ve been on multiple daily injection therapy
More informationThe National DAFNE Audit
The National DAFNE Audit Data Quality and Centre Performance David Hopkins King s College Hospital, London DAFNE Collaborative 26 th June 2015 Why audit matters Audit has been at the centre of DAFNE since
More information10 Common Mistakes of Beginning Researchers. Prof Barbara Anderson and Carmel Smart
10 Common Mistakes of Beginning Researchers Prof Barbara Anderson and Carmel Smart ISPAD Science School for Health Professionals Objectives To increase awareness of common mistakes made by beginning researchers
More informationAdvances in Managing Diabetes in Youth. March 1, 2012
Advances in Managing Diabetes in Youth March 1, 2012 Diabetes in Youth: An Update The Problem Increasing Incidence of Type 1 Diabetes The Cause New Information on an Enterovirus connection New Therapy
More informationDiabetes Care 36: , 2013
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect
More information2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.
Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives
More informationDiabetes and Pregnancy
Diabetes and Pregnancy Dr Warren Gillibrand Deputy Director of Postgraduate Education Department of Nursing & Midwifery Department of AHP and Sports Science w.p.gillibrand@hud.ac.uk Aims of the session
More informationSUPPLEMENTARY DATA. Supplementary Figure 1. Flow diagram of study selection
Supplementary Figure 1. Flow diagram of study selection Supplementary Table 1. Summary of included studies examining the effects of fat, protein and on postprandial glycemia in type 1 diabetes Evidence
More informationDescription. Section: Durable Medical Equipment Effective Date: July 15, 2014 Subsection: Original Policy Date: December 7, 2011 Subject:
Last Review Status/Date: June 2014 Page: 1 of 13 Description Tight glucose control in patients with diabetes has been associated with improved outcomes. Several devices are available to measure glucose
More informationThe New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program
The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women
More informationMedical Policy. MP Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid. Related Policies None
Medical Policy BCBSA Ref. Policy: 1.01.20 Last Review: 11/15/2018 Effective Date: 11/15/2018 Section: Durable Medical Equipment Related Policies None DISCLAIMER Our medical policies are designed for informational
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) June 2017 Review: June 2020 (earlier if required see recommendations) Bulletin 255: Insulin aspart New Formulation - Fiasp JPC Recommendations:
More informationMonitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse
Monitoring in Type 2 Diabetes Senga Hunter Community Diabetes Specialist Nurse Learning Outcomes Understand why blood monitoring is necessary Understand the blood tests for monitoring diabetes Understand
More informationDiabetes Management: Current High Tech Innovations
Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:
More informationUNCOVERING THE BENEFITS OF THE ACCU- CHEK BOLUS ADVISOR MICHAEL PORTER CDE
UNCOVERING THE BENEFITS OF THE ACCU- CHEK BOLUS ADVISOR MICHAEL PORTER CDE 1 LEARNING OBJECTIVES By the end of this session participants should be able to understand: The benefits of bolus advisors The
More informationGESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION A disorder characterised by hyperglycaemia first recognised during pregnancy due to increased insulin resistance
More informationAppendix A Tabular Summary of Pivotal Glucose Monitoring Trials
GM Consensus Statement Appendix, Endocr Pract. 2016;22(No. 2) App1 Appendix A Tabular Summary of Pivotal Glucose Monitoring Trials Wong, et al. Diabetes Care. 2014;37:2702-2709. Table A1 Continuous Glucose
More informationTHE OTHER 50% OF THE TDD PRANDIAL INSULIN ALISON B. EVERT, MS, RD, CDE BIBLIOGRAPHY Evidenced-Based Nutrition Recommendations and Guidelines: Academy of Nutrition and Dietetics: Type 1 and type 2 diabetes
More informationInsulin Initiation, titration & Insulin switch in the Primary Care-KISS
Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Rotorua GP CME 9 June 2012 Dr Kingsley Nirmalaraj FRACP Endocrinologist, BOPDHB & Suite 9, Promed House, Tenth Ave, Tauranga Linda
More informationSubject Index. Breastfeeding, self-monitoring of blood glucose 56
Subject Index Animas Vibe 86, 130 Artificial pancreas clinical studies inpatient studies 175 180 outpatient studies outcome assessment 182, 183 technology 180, 181 telemedicine 182 components glucose sensor
More informationNHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults
NHS Leeds CCG Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults Produced by: Jo Alldred, Medicines Effectiveness Lead, NHS Leeds CCG Dr Bryan Power, Long Term Conditions
More informationINSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد
INSULIN THERAY DIABETES1 IN TYPE دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد Goals of management Manage symptoms Prevent acute and late complications Improve quality of life Avoid
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for
More informationChanging trends in the management of gestational diabetes mellitus
Changing trends in the management of gestational diabetes mellitus Chandrika N Wijeyaratne Dept of Obsterics & Gynaecology University of Colombo 23. 10. 2016 Mrs SL 36 years G3P1C1 POA 8 weeks FBS = 110
More informationDiabetes in Pregnancy: Detection, Intervention, Prevention. Diabetes in Pregnancy: Outline. Diabetes in Pregnancy
Diabetes in Pregnancy: Detection, Intervention, Prevention Michael Shannon, MD Chair, Providence Endocrinology/Diabetes CAT Diabetes in Pregnancy: Outline Prevalence, Pathophysiology and Complications
More informationCarbohydrate Counting In Type 1 Diabetes: What Do We Know?
Carbohydrate Counting In Type 1 Diabetes: What Do We Know? Gail Spiegel, MS RD CDE Barbara Davis Center for Childhood Diabetes Keystone, CO July 2012 Outline Why Count Carbs? Carb counting intervention
More informationWhat is gestational diabetes?
ESPEN Congress Cannes 2003 Organised by the Israel Society for Clinical Nutrition Education and Clinical Practice Programme Session: Dietitian Symposium: Nutrition throughout the woman life cycle An Update
More informationDiabetes Care Publish Ahead of Print, published online April 23, 2015
Diabetes Care 1 Analysis of Continuous Glucose Monitoring in Pregnant Women With Diabetes: Distinct Temporal Patterns of Glucose Associated With Large-for-Gestational-Age Infants Graham R. Law, 1 George
More informationPaolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico
Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna Ipoglicemie e Monitoraggio Glicemico Management of Hypoglycaemia.if hypoglycemia is a problem, the principles
More informationClinical News and Innovation in Type 1 Diabetes and Technology. Parth Narendran University Hospitals Birmingham
Clinical News and Innovation in Type 1 Diabetes and Technology Parth Narendran University Hospitals Birmingham Adjunctive therapy to insulin Accurate diagnosis of T1D Early intensive treatment Technology
More information